DAVID GOLDE Insider Trading
Get free email notifications about insider trading for DAVID GOLDE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID GOLDE. DAVID GOLDE is a Director in ENZON PHARMACEUTICALS, INC. ($ENZN).
Address: C/O ENZON PHARMACEUTICALS, INC. 685 ROUTE 202/206 BRIDGEWATER 08807 NJ
Companies in which DAVID GOLDE is an Insider
ENZON PHARMACEUTICALS, INC.
Trading Symbol: ENZNIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID GOLDE: Director
Holdings: 3,268 shares
Current Value: $1,144
Latest Transaction: Jul 06 2004
$ENZN Market Capitalization: $15.28M
$ENZN Previous Close: $0.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DAVID GOLDE
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 06 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Grant | A | 0.00 | 1,989 | 0 | 3,268 | 1.3 K to 3.3 K (+155.51 %) |
May 19 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Option Exercise | M | 5.50 | 17,320 | 95,260 | 8,000 | |
May 19 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Sell | S | 14.27 | 1,630 | 23,260 | 1,279 | 2.9 K to 1.3 K (-56.03 %) |
May 19 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Sell | S | 14.31 | 400 | 5,724 | 2,909 | 3.3 K to 2.9 K (-12.09 %) |
May 19 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Sell | S | 14.32 | 2,300 | 32,936 | 3,309 | 5.6 K to 3.3 K (-41.01 %) |
May 19 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Sell | S | 14.35 | 1,600 | 22,960 | 5,609 | 7.2 K to 5.6 K (-22.19 %) |
May 19 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Sell | S | 14.37 | 1,000 | 14,370 | 7,209 | 8.2 K to 7.2 K (-12.18 %) |